This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Coulter, D. L. Search for Related Content PubMed PubMed Citation Articles by Coulter, D. L. Social Bookmarking                         What's this?

Review Article: Carnitine, Valproate, and Toxicity

Departments of Pediatrics and Neurology, Boston University School of Medicine, Boston, MA

Carnitine is an important nutrient that is present in the diet (particularly in meat and dairy products) and is synthesized from dietary amino acids. It functions to assist long-chain fatty acid metabolism and to regulate the ratio of free coenzyme A to acylcoenzyme A in the mitochondrion. Carnitine deficiency occurs in primary inborn errors of metabolism, in nutritional deficiency, and in various other disorders including antiepileptic drug therapy. Valproate therapy is often associated with decreased carnitine levels and occasionally with true carnitine deficiency. Some experimental and clinical evidence links valproate-induced carnitine deficiency with hepatotoxicity, but this evidence is limited and inconclusive. Carnitine supplementation has been useful in some studies, but these data are also limited. Young children with neurologic disabilities taking multiple antiepileptic drugs may have the greatest risk for carnitine deficiency. Measurement of carnitine levels appears warranted in these patients and in patients with symptoms and signs of possible carnitine deficiency. (J Child Neurol 1991;6:7-14).

Journal of Child Neurology, Vol. 6, No. 1, 7-14 (1991)
DOI: 10.1177/088307389100600102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. H. Haas, S. Parikh, M. J. Falk, R. P. Saneto, N. I. Wolf, N. Darin, and B. H. Cohen Mitochondrial Disease: A Practical Approach for Primary Care Physicians Pediatrics, December 1, 2007; 120(6): 1326 - 1333. [Abstract] [Full Text] [PDF]

				T. Kagan-Kushnir, S. W. Roberts, and O. C. Snead Screening Electroencephalograms in Autism Spectrum Disorders: Evidence-Based Guideline J Child Neurol, March 1, 2005; 20(3): 197 - 206. [Abstract] [PDF]

				T. P. Bohan, E. Helton, I. McDonald, S. Konig, S. Gazitt, T. Sugimoto, D. Scheffner, L. Cusmano, S. Li, and G. Koch Effect of L-carnitine treatment for valproate-induced hepatotoxicity Neurology, May 22, 2001; 56(10): 1405 - 1409. [Abstract] [Full Text] [PDF]

				M. Fayad, R. Choueiri, and M. Mikati Fatality From Hepatitis A in a Child Taking Valproate J Child Neurol, February 1, 2000; 15(2): 135 - 136. [Abstract] [PDF]

				S.B. Legarda, M.P. Booth, E.B. Fennell, and B.L. Maria Altered Cognitive Functioning in Children With Idiopathic Epilepsy Receiving Valproate Monotherapy J Child Neurol, July 1, 1996; 11(4): 321 - 330. [Abstract] [PDF]

				D. L. Coulter Carnitine Deficiency in Epilepsy: Risk Factors and Treatment J Child Neurol, November 1, 1995; 10(2_suppl): 2S32 - 2S39. [Abstract] [PDF]

				J. T. Gilman Developmental Principles of Antiepileptic Drug Therapy J Child Neurol, October 1, 1994; 9(1_suppl): S20 - S25. [Abstract] [PDF]

				S. L. Bratton, A. L. Garden, T. P. Bohan, J. W. French, and W. R. Clarke A Child With Valproic Acid-Associated Carnitine Deficiency and Carnitine-Responsive Cardiac Dysfunction J Child Neurol, October 1, 1992; 7(4): 413 - 416. [Abstract] [PDF]